Podcasts Archives

Podcasts

Behind the Buyouts: Houlihan's Abelow on PE Resilience in 2025

By Nikitha Sattiraju

Published: July 24th, 2025

Justin Abelow, managing director in Houlihan Lokey's financial sponsors group, discusses PE's resilience in navigating a challenging M&A environment and the alternate structures firms are pursuing for liquidity.

Podcasts

Behind the Buyouts: Schroders Capital's Knox on Evolving GP Landscape

Published: July 21st, 2025

Senior investment director of private equity Jeremy Knox discusses the growth in continuation funds in a tough exit environment, as well as the firm's interest in asset-light services businesses as a co-investor.

Activism

Drinks With The Deal: Wachtell's Kirman, Tetelbaum Discuss Mentorship

Published: July 17th, 2025

Wachtell M&A partners Igor Kirman and Lina Tetelbaum discuss the evolution of their mentor-protege relationship over the past 15 years and how it's enriched their practices and their lives.

Podcasts

Behind the Buyouts: Transact Capital's Karr on Contract Manufacturing Growth

Published: July 16th, 2025

Transact Capital managing director Justin Karr discusses the state of the consumer market in 2025, including private equity interest in contract manufacturing and better-for-you food.

Activism

Activist Investing Today: Litt Targets REIT CEO Pay

By Ronald Orol

Published: July 3rd, 2025

Real estate activist Jonathan Litt discusses concerns that REIT boards often identify distorted peer groups to justify problematic executive pay, as well as why specific directors at 15 REITs should face vote-no campaigns.

M&A

Drinks With The Deal: Gibson Dunn's Scrivani on Managing Job Demands

By David Marcus

Published: July 2nd, 2025

Gibson Dunn M&A partner Brian Scrivani talks about how he handles the stress of legal practice and the importance of maintaining a life outside of work, as well as how he thought about changing law firms.

M&A

Drinks With The Deal: Mintz's Reicin on Finding Meaning in Biotech Work

By David Marcus

Published: June 26th, 2025

Cheryl Reicin, the co-chair of the life sciences group at Mintz, discusses how she became a biotech lawyer and why observing the Sabbath has been good for her as a lawyer.

Activism

Activist Investing Today: Lawndale's Shapiro on 'Problem' Boards

By Ronald Orol

Published: June 25th, 2025

Andrew Shapiro, who ran an activist fund for 32 years, discusses how one campaign helped form his investment vehicle and talks about good and bad investor communication policies.

Activism

Activist Investing Today: Skadden's Breheny on Expected SEC Shifts

By Ronald Orol

Published: June 13th, 2025

Brian Breheny, the former chief of the SEC's M&A division, discusses expected changes to regulations affecting activist investors, including why he thinks the nation's securities regulator can eliminate activist shareholder proposals.

Insights & Analysis

Behind the Buyouts: Houlihan's Abelow on PE Resilience in 2025

Behind the Buyouts: Schroders Capital's Knox on Evolving GP Landscape

Drinks With The Deal: Wachtell's Kirman, Tetelbaum Discuss Mentorship

Behind the Buyouts: Transact Capital's Karr on Contract Manufacturing Growth

Activist Investing Today: Litt Targets REIT CEO Pay

Drinks With The Deal: Gibson Dunn's Scrivani on Managing Job Demands

Drinks With The Deal: Mintz's Reicin on Finding Meaning in Biotech Work

Activist Investing Today: Lawndale's Shapiro on 'Problem' Boards

Activist Investing Today: Skadden's Breheny on Expected SEC Shifts

Join our community of dealmakers and advisers